Diligence memo · auto-generated · as of July 2, 2026
Moonlight Therapeutics Inc.
Moonlight Therapeutics Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Moonlight Therapeutics Inc. operates in Biotechnology, based in MARIETTA.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Moonlight Therapeutics Inc. has raised $2.4M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.4M on 2024-08-01.
Most recent recorded round closed around 2024-08-01.
Valuation (modeled)modeled
Provath models Moonlight Therapeutics Inc. at approximately $11M (range $1.7M–$29M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.79× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era. Within the normal band (79% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 23 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 31% of Biotechnology peers (4293 compared).
Modeled value ranks above 20% of those peers.
Closest niche peers: Mesentech Inc., Marlinspike Therapeutics, Inc., Microbial Machines, Inc., Pearl Diagnostics, Inc., Crossfire Medical Inc.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.